Cargando…
Raynaud’s Secondary to Granulomatosis With Polyangiitis
Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481133/ https://www.ncbi.nlm.nih.gov/pubmed/34646608 http://dx.doi.org/10.7759/cureus.17551 |
_version_ | 1784576617547300864 |
---|---|
author | Vulasala, Sai Swarupa Ahmed, Shohana Onteddu, Nirmal K Mannem, Maneesh Mukkera, Srikanth |
author_facet | Vulasala, Sai Swarupa Ahmed, Shohana Onteddu, Nirmal K Mannem, Maneesh Mukkera, Srikanth |
author_sort | Vulasala, Sai Swarupa |
collection | PubMed |
description | Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA) that presented with ischemia and gangrene. Studies show that approximately <1% of GPA cases have similar presentations. Early diagnosis and management are essential to halt the progression of ischemia. Calcium channel blockers are the first-line medications used in RP. Phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, and prostacyclin analogs are proven to be effective in cases of severe RP. Sympathectomy and amputation are considered as the extreme options in patients with refractory symptoms. |
format | Online Article Text |
id | pubmed-8481133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-84811332021-10-12 Raynaud’s Secondary to Granulomatosis With Polyangiitis Vulasala, Sai Swarupa Ahmed, Shohana Onteddu, Nirmal K Mannem, Maneesh Mukkera, Srikanth Cureus Dermatology Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA) that presented with ischemia and gangrene. Studies show that approximately <1% of GPA cases have similar presentations. Early diagnosis and management are essential to halt the progression of ischemia. Calcium channel blockers are the first-line medications used in RP. Phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, and prostacyclin analogs are proven to be effective in cases of severe RP. Sympathectomy and amputation are considered as the extreme options in patients with refractory symptoms. Cureus 2021-08-30 /pmc/articles/PMC8481133/ /pubmed/34646608 http://dx.doi.org/10.7759/cureus.17551 Text en Copyright © 2021, Vulasala et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Dermatology Vulasala, Sai Swarupa Ahmed, Shohana Onteddu, Nirmal K Mannem, Maneesh Mukkera, Srikanth Raynaud’s Secondary to Granulomatosis With Polyangiitis |
title | Raynaud’s Secondary to Granulomatosis With Polyangiitis |
title_full | Raynaud’s Secondary to Granulomatosis With Polyangiitis |
title_fullStr | Raynaud’s Secondary to Granulomatosis With Polyangiitis |
title_full_unstemmed | Raynaud’s Secondary to Granulomatosis With Polyangiitis |
title_short | Raynaud’s Secondary to Granulomatosis With Polyangiitis |
title_sort | raynaud’s secondary to granulomatosis with polyangiitis |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481133/ https://www.ncbi.nlm.nih.gov/pubmed/34646608 http://dx.doi.org/10.7759/cureus.17551 |
work_keys_str_mv | AT vulasalasaiswarupa raynaudssecondarytogranulomatosiswithpolyangiitis AT ahmedshohana raynaudssecondarytogranulomatosiswithpolyangiitis AT onteddunirmalk raynaudssecondarytogranulomatosiswithpolyangiitis AT mannemmaneesh raynaudssecondarytogranulomatosiswithpolyangiitis AT mukkerasrikanth raynaudssecondarytogranulomatosiswithpolyangiitis |